Compare Novavax Inc (NVAX) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Quantumscape Corp — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while Quantumscape Corp trades at $6.37 (market cap $3.90B). The key difference: Quantumscape Corp is far larger — about 3× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals.
| NVAX | QS | |
|---|---|---|
Market Cap | $1.31B | $3.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $18.44 |
52-Week Low | $6.22 | $4.89 |
Enterprise Value | $889.30M | $3.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
